Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-12-11, Stock:JNJ, The news for the past five days is as follows:
2020-12-04: NEWS1: The biggest challenges facing vaccine distribution.NEWS2: The Zacks Analyst Blog Highlights: Apple, Berkshire Hathaway, Johnson & Johnson, Lockheed Martin and PNC Financial Services Group.NEWS3: A Trio of Stock Picks for a 'Buy and Hold' Approach.NEWS4: J&J (JNJ) Files BLA for Lung Cancer Candidate Amivantamab.NEWS5: Pharma Stock Roundup: Approval of PFE/BNTX Coronavirus Vaccine in UK, Other Updates.NEWS6: Best Bet in a Down Year: The Dividend Aristocrats.NEWS7: 3 COVID Vaccine Stocks to Invest in for the Long Run.
2020-12-07: NEWS1: People who get injured from COVID-19 vaccines could have a hard time getting compensated.NEWS2: Fate Stock Soars After Novel Natural-Killer Treatment for Cancers Makes a Splash.NEWS3: Race for Multiple Myeloma Drugs Not Moving Stocks — Yet.
2020-12-08: NEWS1: GLOBAL MARKETS-Stocks rise after upbeat vaccine news; sterling slips.NEWS2: US STOCKS-Wall Street closes higher on vaccine lift; S&P 500, Nasdaq at records.NEWS3: US STOCKS-Wall St closes higher on vaccine lift.NEWS4: US STOCKS-Vaccine boost helps send Wall Street to record.NEWS5: GLOBAL MARKETS-Stocks edge up following upbeat vaccine news; sterling dips.NEWS6: US STOCKS-Nasdaq touches record high; Dow, S&P 500 lifted by J&J.NEWS7: Dow Jones Leads As Nasdaq Struggles, Tesla Stock Slides On This Move.NEWS8: US STOCKS-Wall St slips on rising coronavirus cases, Tesla drags Nasdaq lower.NEWS9: 3 COVID Stocks Not To Neglect.NEWS10: P/E Ratio Insights for Johnson & Johnson.
2020-12-09: NEWS1: Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know.NEWS2: Markets Book Profits as Vaccine Rally Stalls; DASH Jumps 86% on IPO.NEWS3: Nasdaq Hit Hard After A 1,785-Point Run Since Oct. 30; Will These Top Stocks Break Out?.NEWS4: Former Allergan CEO: Pfizer's $19.50 COVID-19 vaccine dose price 'is a pretty good bargain'.NEWS5: 10 Dividend Stocks Warren Buffett Likes the Most.NEWS6: Heading into Christmas 'we’ll see a spike on top of a spike': Doctor on COVID spread.NEWS7: Moderna Will Succeed, but Its Stock Already Reflects That, Says Needham.NEWS8: IPO Market Set to Thrive in December.NEWS9: 2 Robinhood Stocks That Can Survive Another Market Crash.NEWS10: Curis (CRIS) Skyrockets on Promising Phase I Pipeline Updates.NEWS11: US STOCKS-S&P 500 set for record open on vaccine, stimulus bets.NEWS12: New Investor? Here Are 3 Great Starter Stocks.NEWS13: Is Johnson & Johnson a Great Dividend Stock?.NEWS14: After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?.NEWS15: Corporate America will truly be addressing racial justice when it ‘costs something’: Michael Eric Dyson.NEWS16: Mexico says could order 22 mln more vaccine doses from J&J.NEWS17: Johnson & Johnson Expects Vaccine Trial Results in January.
2020-12-10: NEWS1: Becton Dickinson Expects Covid Testing Sales to Hit $1.5 Billion.NEWS2: Pfizer, BioNTech Nab FDA Panel Recommendation For Covid Vaccine.NEWS3: FDA Committee Nears Key Vote On Pfizer, BioNTech's Covid Vaccine.NEWS4: FDA Committee Takes Up Pfizer, BioNTech Coronavirus Vaccine.NEWS5: Melinda Gates: Half the U.S. could be vaccinated by mid-2021.NEWS6: Melinda Gates: We have a moral responsibility to make sure everybody gets COVID-19 vaccine.NEWS7: This Magic Mushroom Stock Is Worth Your Money Right Now.NEWS8: Pfizer Stock Faces Its Next Big Covid Challenge: An FDA Committee.NEWS9: Forget Moderna! These 2 Stocks May be the Biggest Winners of the Vaccine Race.NEWS10: Oklahoma seeks $9.3 billion from Johnson & Johnson over opioid crisis.

Answer: Rise